[
  {
    "ts": null,
    "headline": "Why Hologic (HOLX) Outpaced the Stock Market Today",
    "summary": "In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=5418a8b16aaaa9bebe5946d8f044414649ffb9a5d3f4306f031ebd749c797d8b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759441504,
      "headline": "Why Hologic (HOLX) Outpaced the Stock Market Today",
      "id": 136960729,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Hologic (HOLX) stood at $67.91, denoting a +1.3% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=5418a8b16aaaa9bebe5946d8f044414649ffb9a5d3f4306f031ebd749c797d8b"
    }
  },
  {
    "ts": null,
    "headline": "Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025",
    "summary": "MARLBOROUGH, Mass., October 02, 2025--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025",
    "url": "https://finnhub.io/api/news?id=4a72c05461d46d90be3f1ef52a7fc41872905dc05617a1efa5b0151051bb5931",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759435440,
      "headline": "Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025",
      "id": 136960730,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "MARLBOROUGH, Mass., October 02, 2025--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025",
      "url": "https://finnhub.io/api/news?id=4a72c05461d46d90be3f1ef52a7fc41872905dc05617a1efa5b0151051bb5931"
    }
  },
  {
    "ts": null,
    "headline": "Hologic (HOLX): Assessing Valuation Following Upbeat Earnings, Guidance Boost, and New Partnership Moves",
    "summary": "Hologic (HOLX) recently surprised Wall Street by delivering higher revenues and strong earnings growth, which prompted the company to lift its full-year guidance. The announcement came alongside new partnerships and increased visibility around breast cancer awareness. See our latest analysis for Hologic. While Hologic has delivered upbeat earnings and continued to invest in growth partnerships this quarter, its share price has not yet reflected the underlying progress. The stock’s 1-year...",
    "url": "https://finnhub.io/api/news?id=030ef1dcbe1e3f151cfd39a33e9b50c56023540aa1262cb24f018895f54388c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759424317,
      "headline": "Hologic (HOLX): Assessing Valuation Following Upbeat Earnings, Guidance Boost, and New Partnership Moves",
      "id": 136960731,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Hologic (HOLX) recently surprised Wall Street by delivering higher revenues and strong earnings growth, which prompted the company to lift its full-year guidance. The announcement came alongside new partnerships and increased visibility around breast cancer awareness. See our latest analysis for Hologic. While Hologic has delivered upbeat earnings and continued to invest in growth partnerships this quarter, its share price has not yet reflected the underlying progress. The stock’s 1-year...",
      "url": "https://finnhub.io/api/news?id=030ef1dcbe1e3f151cfd39a33e9b50c56023540aa1262cb24f018895f54388c7"
    }
  },
  {
    "ts": null,
    "headline": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=e0808dae5452614281423bd120f097c593e2f604c7f03abac32b35e61351cc9d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759412403,
      "headline": "Are You a Value Investor? This 1 Stock Could Be the Perfect Pick",
      "id": 136960732,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=e0808dae5452614281423bd120f097c593e2f604c7f03abac32b35e61351cc9d"
    }
  },
  {
    "ts": null,
    "headline": "Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis",
    "summary": "MARLBOROUGH, Mass., October 02, 2025--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fusion® Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The company also announced that the assays obtained CE marking in the European Union in accordance with In Vitro Diagnostic Regulation (IVDR). These highly sensitive molecular tests are designed to rapidly detect the most common bacterial pathogens res",
    "url": "https://finnhub.io/api/news?id=1a50c67019c6c925685ae1f6f12a73ba87e25362dd093c69ef2335146257937c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759406700,
      "headline": "Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis",
      "id": 136955720,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HOLX",
      "source": "Yahoo",
      "summary": "MARLBOROUGH, Mass., October 02, 2025--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fusion® Gastrointestinal (GI) Bacterial and Expanded Bacterial Assays. The company also announced that the assays obtained CE marking in the European Union in accordance with In Vitro Diagnostic Regulation (IVDR). These highly sensitive molecular tests are designed to rapidly detect the most common bacterial pathogens res",
      "url": "https://finnhub.io/api/news?id=1a50c67019c6c925685ae1f6f12a73ba87e25362dd093c69ef2335146257937c"
    }
  }
]